2020 | Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study | TARGETED ONCOLOGY |
2024 | Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06)
| BMC CANCER |
2022 | Real-world practice patterns and characteristics of adverse events with selexipag in Korean patients with pulmonary arterial hypertension | EXPERT OPINION ON DRUG SAFETY |
2022 | Real-World Prescription Patterns and Barriers Related to the Use of Sodium-Glucose Cotransporter 2 Inhibitors among Korean Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease
| DIABETES & METABOLISM JOURNAL |
2023 | Real-world Prescription Patterns and Patient Satisfaction Regarding Maintenance Therapy of Gastroesophageal Reflux Disease: An Observational, Cross-sectional, Multicenter Study
| JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY |
2022 | Real-world prevalence of MSI-H/dMMR across 6 different tumor types in Asia | ANNALS OF ONCOLOGY |
2023 | Real-World Safety and Clinical Outcomes of Macitentan in Asian Patients with Pulmonary Arterial Hypertension: A Prospective Multicenter Study
| DRUGS-REAL WORLD OUTCOMES |
2022 | Real-world Safety and Effectiveness of Denosumab in Patients With Osteoporosis: A Prospective, Observational Study in South Korea
| Endocrinology and Metabolism(대한내분비학회지) |
2023 | Real-World Study Evaluating Safety and Effectiveness of Axitinib in Korean Patients with Renal Cell Carcinoma after Failure of One Prior Systemic Therapy
| CANCER RESEARCH AND TREATMENT |
2023 | Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer
| CANCER RESEARCH AND TREATMENT |
2021 | Real-world systemic sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Korea | INVESTIGATIONAL NEW DRUGS |
2022 | Real-world treatment outcomes of amivantamab in pre-approval access (PAA) participants with advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations (ex20ins) | ANNALS OF ONCOLOGY |
2021 | Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III NSCLC: Results of KINDLE, a Multicountry Observational Study
| JOURNAL OF THORACIC ONCOLOGY |
2020 | Real-world Use of Osimertinib in Non-Small Cell Lung Cancer: ASTRIS Study Korean Subgroup Analysis | CURRENT MEDICAL RESEARCH AND OPINION |
2020 | Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS) | EUROPACE |
2020 | Reappraisal of the treatment duration of antibiotic regimens for acute uncomplicated cystitis in adult women: a systematic review and network meta-analysis of 61 randomised clinical trials | LANCET INFECTIOUS DISEASES |
2016 | Reappraisal of waist circumference cutoff value according to general obesity
| NUTRITION & METABOLISM |
2020 | Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B | JOURNAL OF HEPATOLOGY |
2015 | Reassessing the Usefulness of Coronary Artery Calcium Score among Varying Racial and Ethnic Groups by Geographic Locations: Relevance of the Korea Initiatives on Coronary Artery Calcification Registry.
| Journal of Cardiovascular Ultrasound |
2017 | Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma
| CANCER MEDICINE |